Unknown

Dataset Information

0

MC32 tumor cells acquire Ag-specific CTL resistance through the loss of CEA in a colon cancer model.


ABSTRACT: We previously reported that MC32 cells resist carcinoembryonic antigen (CEA) DNA vaccination by losing their antigen presentation to Ag-specific CTLs in the context of MHC class I antigens in a colon cancer therapeutic model. In this study, we selected 2 tumor cells, MC32-S2-2 and MC32-S4-2, which have the ability to form tumors in CEA DNA vaccine-immunized mice. Wild type MC32 cells grew significantly less in CEA-immunized mice (with Ag-specific CTL lytic activity) than in control mice (with no Ag-specific CTL lytic activity). However, MC32-S2-2 and MC32-S4-2 cells grew at a similar rate in both control and CEA-immunized mice, confirming their resistant status against CEA DNA vaccination. MC32-S2-2 and MC32-S4-2 cells were not susceptible to lysis by CEA-specific CD8+ T cells. Moreover, when MC32-S2-2 and MC32-S4-2 cells were used as stimulating agents of CEA-specific immune cells for IFN-? production, these cells failed to stimulate the induction of Ag-specific IFN-?, suggesting a loss of tumor cell recognition by Ag-specific immune cells. However, MC32-S2-2 and MC32-S4-2 cells expressed MHC class I antigens in a manner similar to that of wild type MC32 cells. Finally, Western blot assay confirmed that in MC32-S2-2 and MC32-S4-2 cells, CEA expression remained absent but mouse CEA was expressed. Taken together, these data show that MC32 cells may also be able to achieve resistance to CEA-specific CTLs by antigen loss in this model.

SUBMITTER: Lee SY 

PROVIDER: S-EPMC4635946 | biostudies-literature | 2015

REPOSITORIES: biostudies-literature

altmetric image

Publications

MC32 tumor cells acquire Ag-specific CTL resistance through the loss of CEA in a colon cancer model.

Lee Sang-Yeul SY   Sin Jeong-Im JI  

Human vaccines & immunotherapeutics 20150101 8


We previously reported that MC32 cells resist carcinoembryonic antigen (CEA) DNA vaccination by losing their antigen presentation to Ag-specific CTLs in the context of MHC class I antigens in a colon cancer therapeutic model. In this study, we selected 2 tumor cells, MC32-S2-2 and MC32-S4-2, which have the ability to form tumors in CEA DNA vaccine-immunized mice. Wild type MC32 cells grew significantly less in CEA-immunized mice (with Ag-specific CTL lytic activity) than in control mice (with no  ...[more]

Similar Datasets

| S-EPMC5353923 | biostudies-literature
| S-EPMC4180868 | biostudies-literature
| S-EPMC5457157 | biostudies-literature
| S-EPMC4073440 | biostudies-literature
| S-EPMC2835135 | biostudies-literature
| S-EPMC4966325 | biostudies-literature
| S-EPMC5842239 | biostudies-literature
| S-EPMC3690550 | biostudies-literature
| S-EPMC3311364 | biostudies-literature
| S-EPMC5491702 | biostudies-other